Crescent Biopharma CBIO Revenue Breakdown

NASDAQ CBIO
$13.24 +0.07 (+0.55%)
As of: Oct 22, 2026 · 3:19 PM EDT
No revenue breakdown for CBIO Crescent Biopharma does not report revenue split by segment, product or geography.